Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;27(5):436-442.
doi: 10.1111/ijpp.12484. Epub 2018 Sep 12.

Development of intervention-related quality indicators for renal clinical pharmacists using a modified Delphi approach

Katherine Boutin  1 , William Nevers  1 , Sean K Gorman  2 , Richard S Slavik  2 , Daniel J Martinusen  3 , Clifford Lo  4
Affiliations

Development of intervention-related quality indicators for renal clinical pharmacists using a modified Delphi approach

Katherine Boutin et al. Int J Pharm Pract. 2019 Oct.

Abstract

Objective: To develop a list of renal Quality Indicator Drug therapy problems (QI-DTPs) that serve to advance renal pharmacy practice to improve patient care.

Methods: Eighteen (18) renal, clinical pharmacists participated in an internet-based three-round modified Delphi survey. Each of the three rounds took approximately 2 weeks to complete. Panellists rated 30-candidate renal QI-DTPs using seven selection criteria and one overall consensus criterion on a nine-point Likert scale. Consensus was reached if 75% or more of panellists assigned a score of 7-9 on the consensus criterion during the third Delphi round.

Key findings: All panellists completed three rounds of Delphi survey. Seventeen-candidate renal QI-DTPs met the consensus definition.

Conclusions: A Delphi panel of renal clinical pharmacists successfully identified 17 consensus renal QI-DTPs. Assessment and implementation of these QI-DTPs will serve to advance renal pharmacy practice and improve patient care.

Keywords: clinical interventions; clinical pharmacy; pharmaceutical care; professional practice.

PubMed Disclaimer

References

    1. Coresh J et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
    1. Arora P et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 2013; 185: E417-E423.
    1. Cardone KE et al. Medication-related problems in CKD. Adv Chronic Kidney Dis 2010; 17: 404-412.
    1. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice - The Clinician's Guide. New York, NY: The McGraw-Hill Companies, Inc., 2004.
    1. Bruchet N, Loewen P, de Lemos J. Improving the quality of clinical pharmacy services: a process to identify and capture high-value “quality actions”. Can J Hosp Pharm 2011; 64: 42-47.

MeSH terms